Medline
$35.61Change from previous close: +1.92%Absolute change: +$0.67
At a glance
- Net margin
- 4.1%
- 2025
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | 715 | 412 | 229 | — | 197 | 682 |
| Depreciation and amortization | 256 | 254 | 261 | — | 250 | 247 |
| Capital expenditure | -111 | -96.0 | -138 | — | -110 | -98.0 |
| Investing cash flow | -461 | -96.0 | -138 | — | -143 | -92.0 |
| Financing cash flow | -159 | -13.0 | 897 | — | -328 | -9.0 |
| Dividends paid | — | — | -96.0 | — | — | — |
| Share repurchases | 0.0 | 0.0 | -1,970 | — | -6.0 | -9.0 |
| Debt issued | 4,733 | 0.0 | 0.0 | — | 0.0 | 179 |
| Debt repaid | -4,771 | 0.0 | -4,049 | — | -19.0 | -179 |
| Effect of exchange rates | -4.0 | -7.0 | -1.0 | — | 18.0 | 9.0 |
| Net change in cash | 95.0 | 303 | 988 | — | -274 | 581 |
| Free cash flow | 604 | 316 | 91.0 | — | 87.0 | 584 |